Complement and Antibody-mediated Enhancement of Red Blood Cell Invasion and Growth of Malaria Parasites

EBioMedicine

Volumn 9, Issue , 2016, Pages 207-216

  Biryukov, Sergei ^a   Angov, Evelina ^b   Landmesser, Mary E ^a   Spring, Michele D ^b   Ockenhouse, Christian F ^c   Stoute, José A ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c PATH Malaria Vaccine Initiative   (United States)

Author keywords

Complement; CR1; Malaria; Merozoites; Red blood cells

Indexed keywords

COMPLEMENT COMPONENT C3B RECEPTOR; MEROZOITE SURFACE PROTEIN 1; MONOCLONAL ANTIBODY; COMPLEMENT RECEPTOR; IMMUNOGLOBULIN G; PROTOZOAL PROTEIN; PROTOZOAL VACCINE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INVASION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ERYTHROCYTE; FLOW CYTOMETRY; IMMUNOFLUORESCENCE; MALARIA; MEROZOITE; MOUSE; NONHUMAN; PARASITEMIA; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; ANIMAL; C57BL MOUSE; CAPPING PHENOMENON; CELL ADHESION; CELL CULTURE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMMUNOLOGY; METABOLISM; PARASITOLOGY; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; VETERINARY;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL ADHESION; CELLS, CULTURED; ERYTHROCYTES; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULIN G; MALARIA; MEROZOITES; MICE; MICE, INBRED C57BL; MICROSCOPY, CONFOCAL; PARASITEMIA; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; PROTOZOAN VACCINES; RECEPTOR AGGREGATION; RECEPTORS, COMPLEMENT;

EID: 84973661538     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2016.05.015     Document Type: Article

References (60)

1. Angov, E., Aufiero, B.M., Turgeon, A.M., Van, H.M., Ockenhouse, C.F., Kester, K.E., Walsh, D.S., McBride, J.S., Dubois, M.C., Cohen, J., et al. Development and pre-clinical analysis of a Plasmodium falciparum Merozoite Surface Protein-1(42) malaria vaccine. Mol. Biochem. Parasitol. 128 (2003), 195–204.
2. Araujo, M.N., Leser, P.G., Gabriel, J.A., Assad, R.L., Atra, E., A simple radial immunohemolysis assay for the measurement of functional complement C2 activity. Braz. J. Med. Biol. Res. 24 (1991), 49–57.
3. Arumugam, T.V., Tang, S.C., Lathia, J.D., Cheng, A., Mughal, M.R., Chigurupati, S., Magnus, T., Chan, S.L., Jo, D.G., Ouyang, X., et al. Intravenous immunoglobulin (IVIG) protects the brain against experimental stroke by preventing complement-mediated neuronal cell death. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 14104–14109.
4. Boyle, M.J., Wilson, D.W., Richards, J.S., Riglar, D.T., Tetteh, K.K., Conway, D.J., Ralph, S.A., Baum, J., Beeson, J.G., Isolation of viable plasmodium falciparum merozoites to define erythrocyte invasion events and advance vaccine and drug development. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 14378–14383.
5. Boyle, M.J., Reiling, L., Feng, G., Langer, C., Osier, F.H., Aspeling-Jones, H., Cheng, Y.S., Stubbs, J., Tetteh, K.K., Conway, D.J., et al. Human antibodies fix complement to inhibit plasmodium falciparum invasion of erythrocytes and are associated with protection against malaria. Immunity 42 (2015), 580–590.
6. Cavinato, R.A., Bastos, K.R., Sardinha, L.R., Elias, R.M., Alvarez, J.M., d'Imperio Lima, M.R., Susceptibility of the different developmental stages of the asexual (schizogonic) erythrocyte cycle of Plasmodium chabaudi chabaudi to hyperimmune serum, immunoglobulin (Ig)G1, IgG2a and F(ab′)2 fragments. Parasite Immunol. 23 (2001), 587–597.
7. Chang, S.P., Gibson, H.L., Lee-Ng, C.T., Barr, P.J., Hui, G.S., A carboxyl-terminal fragment of plasmodium falciparum gp195 expressed by a recombinant baculovirus induces antibodies that completely inhibit parasite growth. J. Immunol. 149 (1992), 548–555.
8. Cohen, S., McGregor, I.A., Carrington, S., Gamma-globulin and acquired immunity to human malaria. Nature 192 (1961), 733–737.
9. Da Silva, R.P., Hall, B.F., Joiner, K.A., Sacks, D.L., CR1, the C3b receptor, mediates binding of infective Leishmania major metacyclic promastigotes to human macrophages. J. Immunol. 143 (1989), 617–622.
10. Darko, C.A., Angov, E., Collins, W.E., Bergmann-Leitner, E.S., Girouard, A.S., Hitt, S.L., McBride, J.S., Diggs, C.L., Holder, A.A., Long, C.A., et al. The clinical-grade 42-kilodalton fragment of merozoite surface protein 1 of Plasmodium falciparum strain FVO expressed in Escherichia coli protects Aotus nancymai against challenge with homologous erythrocytic-stage parasites. Infect. Immun. 73 (2005), 287–297.
11. Datta, P.K., Rappaport, J., HIV and complement: hijacking an immune defense. Biomed. Pharmacother. 60 (2006), 561–568.
12. Davies, K.A., Hird, V., Stewart, S., Sivolapenko, G.B., Jose, P., Epenetos, A.A., Walport, M.J., A study of in vivo immune complex formation and clearance in man. J. Immunol. 144 (1990), 4613–4620.
13. Fearon, D.T., Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte. J. Exp. Med. 152 (1980), 20–30.
14. Ghiran, I., Barbashov, S.F., Klickstein, L.B., Tas, S.W., Jensenius, J.C., Nicholson-Weller, A., Complement receptor 1/CD35 is a receptor for mannan-binding lectin. J. Exp. Med. 192 (2000), 1797–1808.
15. Guevara Patino, J.A., Holder, A.A., McBride, J.S., Blackman, M.J., Antibodies that inhibit malaria merozoite surface protein-1 processing and erythrocyte invasion are blocked by naturally acquired human antibodies. J. Exp. Med. 186 (1997), 1689–1699.
16. Harboe, M., Mollnes, T.E., The alternative complement pathway revisited. J. Cell. Mol. Med. 12 (2008), 1074–1084.
17. Harboe, M., Ulvund, G., Vien, L., Fung, M., Mollnes, T.E., The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation. Clin. Exp. Immunol. 138 (2004), 439–446.
18. Hartung, H.P., Advances in the understanding of the mechanism of action of IVIg. J. Neurol. 255:Suppl. 3 (2008), 3–6.
19. Haynes, J.D., Moch, J.K., Smoot, D.S., Erythrocytic malaria growth or invasion inhibition assays with emphasis on suspension culture GIA. Methods Mol. Med. 72 (2002), 535–554.
20. Jarra, W., Hills, L.A., March, J.C., Brown, K.N., Protective immunity to malaria. Studies with cloned lines of Plasmodium chabaudi chabaudi and P. berghei in CBA/Ca mice. II. The effectiveness and inter- or intra-species specificity of the passive transfer of immunity with serum. Parasite Immunol. 8 (1986), 239–254.
21. Kaslow, D.C., Hui, G., Kumar, S., Expression and antigenicity of Plasmodium falciparum major merozoite surface protein (MSP1(19)) variants secreted from Saccharomyces cerevisiae. Mol. Biochem. Parasitol. 63 (1994), 283–289.
22. Kennedy, M.C., Wang, J., Zhang, Y., Miles, A.P., Chitsaz, F., Saul, A., Long, C.A., Miller, L.H., Stowers, A.W., In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1): production and activity of an AMA1 vaccine and generation of a multiallelic response. Infect. Immun. 70 (2002), 6948–6960.
23. Kennedy, A.T., Schmidt, C.Q., Thompson, J.K., Weiss, G.E., Taechalertpaisarn, T., Gilson, P.R., Barlow, P.N., Crabb, B.S., Cowman, A.F., Tham, W.H., Recruitment of factor H as a novel complement evasion strategy for blood-stage Plasmodium falciparum infection. J. Immunol. 196 (2016), 1239–1248.
24. Lambros, C., Vanderberg, J.P., Synchronization of Plasmodium falciparum erythrocytic stages in culture. J. Parasitol. 65 (1979), 418–420.
25. Lutz, H.U., Jelezarova, E., Complement amplification revisited. Mol. Immunol. 43 (2006), 2–12.
26. Mastellos, D.C., Yancopoulou, D., Kokkinos, P., Huber-Lang, M., Hajishengallis, G., Biglarnia, A.R., Lupu, F., Nilsson, B., Risitano, A.M., Ricklin, D., et al. Compstatin: a C3-targeted complement inhibitor reaching its prime for bedside intervention. Eur. J. Clin. Investig. 45 (2015), 423–440.
27. McGregor, I.A., The passive transfer of human malarial immunity. Am.J.Trop. Med. Hyg. 13 (1964), 237–239.
28. McGregor, I.A., The passive transfer of human malarial immunity. Am.J.Trop. Med. Hyg. 13 (1964), 237–239.
29. Miller, L.H., Aikawa, M., Johnson, J.G., Shiroishi, T., Interaction between cytochalasin B-treated malarial parasites and erythrocytes. Attachment and junction formation. J. Exp. Med. 149 (1979), 172–184.
30. Mitchell, G.H., Hadley, T.J., McGinniss, M.H., Klotz, F.W., Miller, L.H., Invasion of erythrocytes by Plasmodium falciparum malaria parasites: evidence for receptor heterogeneity and two receptors. Blood 67 (1986), 1519–1521.
31. Molina, H., The murine complement regulator Crry: new insights into the immunobiology of complement regulation. Cell. Mol. Life Sci. 59 (2002), 220–229.
32. Moll, K., Ljungstrom, I., Perlmann, H., Scherf, A., Wahlgren, M., Moll, K., Ljungstrom, I., Perlmann, H., Scherf, A., Wahlgren, M., (eds.) Methods in Malaria Research, fifth ed., 2008, MR4/ATCC, Manassas.
33. Morgan, B.P., Morgan, B.P., (eds.) Complement Methods and Protocols, 2000, Humana Press, Totowa, New Jersey, 61–75.
34. Murray, C.J., Rosenfeld, L.C., Lim, S.S., Andrews, K.G., Foreman, K.J., Haring, D., Fullman, N., Naghavi, M., Lozano, R., Lopez, A.D., Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet 379 (2012), 413–431.
35. Nilsson, U.R., Funke, L., Nilsson, B., Ekdahl, K.N., Two conformational forms of target-bound iC3b that distinctively bind complement receptors 1 and 2 and two specific monoclonal antibodies. Ups. J. Med. Sci. 116 (2011), 26–33.
36. Ogutu, B.R., Apollo, O.J., McKinney, D., Okoth, W., Siangla, J., Dubovsky, F., Tucker, K., Waitumbi, J.N., Diggs, C., Wittes, J., et al. Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya. PLoS One, 4, 2009, e4708.
37. Otsyula, N., Angov, E., Bergmann-Leitner, E., Koech, M., Khan, F., Bennett, J., Otieno, L., Cummings, J., Andagalu, B., Tosh, D., et al. Results from tandem Phase 1 studies evaluating the safety, reactogenicity and immunogenicity of the vaccine candidate antigen Plasmodium falciparum FVO merozoite surface protein-1 (MSP1(42)) administered intramuscularly with adjuvant system AS01. Malar. J., 12, 2013, 29.
38. Pouw, R.B., Vredevoogd, D.W., Kuijpers, T.W., Wouters, D., Of mice and men: the factor H protein family and complement regulation. Mol. Immunol. 67 (2015), 12–20.
39. Ramos, T.N., Darley, M.M., Weckbach, S., Stahel, P.F., Tomlinson, S., Barnum, S.R., The C5 convertase is not required for activation of the terminal complement pathway in murine experimental cerebral malaria. J. Biol. Chem. 287 (2012), 24734–24738.
40. Ricklin, D., Hajishengallis, G., Yang, K., Lambris, J.D., Complement: a key system for immune surveillance and homeostasis. Nat. Immunol. 11 (2010), 785–797.
41. Rosa, T.F., Flammersfeld, A., Ngwa, C.J., Kiesow, M., Fischer, R., Zipfel, P.F., Skerka, C., Pradel, G., The Plasmodium falciparum blood stages acquire factor H family proteins to evade destruction by human complement. Cell. Microbiol. 18 (2016), 573–590.
42. Rotman, H.L., Daly, T.M., Clynes, R., Long, C.A., Fc receptors are not required for antibody-mediated protection against lethal malaria challenge in a mouse model. J. Immunol. 161 (1998), 1908–1912.
43. Sabchareon, A., Burnouf, T., Ouattara, D., Attanath, P., Bouharoun-Tayoun, H., Chantavanich, P., Foucault, C., Chongsuphajaisiddhi, T., Druilhe, P., Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria. Am.J.Trop. Med. Hyg. 45 (1991), 297–308.
44. Sagara, I., Dicko, A., Ellis, R.D., Fay, M.P., Diawara, S.I., Assadou, M.H., Sissoko, M.S., Kone, M., Diallo, A.I., Saye, R., et al. A randomized controlled phase 2 trial of the blood stage AMA1-C1/Alhydrogel malaria vaccine in children in Mali. Vaccine 27 (2009), 3090–3098.
45. Sahu, A., Kay, B.K., Lambris, J.D., Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library. J. Immunol. 157 (1996), 884–891.
46. Schlesinger, L.S., Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J. Immunol. 150 (1993), 2920–2930.
47. Schlesinger, L.S., Bellinger-Kawahara, C.G., Payne, N.R., Horwitz, M.A., Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. J. Immunol. 144 (1990), 2771–2780.
48. Siddiqui, W.A., Tam, L.Q., Kan, S.C., Kramer, K.J., Case, S.E., Palmer, K.L., Yamaga, K.M., Hui, G.S., Induction of protective immunity to monoclonal-antibody-defined Plasmodium falciparum antigens requires strong adjuvant in Aotus monkeys. Infect. Immun. 52 (1986), 314–318.
49. Singh, S., Kennedy, M.C., Long, C.A., Saul, A.J., Miller, L.H., Stowers, A.W., Biochemical and immunological characterization of bacterially expressed and refolded Plasmodium falciparum 42-kilodalton C-terminal merozoite surface protein 1. Infect. Immun. 71 (2003), 6766–6774.
50. Singh, S., Miura, K., Zhou, H., Muratova, O., Keegan, B., Miles, A., Martin, L.B., Saul, A.J., Miller, L.H., Long, C.A., Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity. Infect. Immun. 74 (2006), 4573–4580.
51. Spadafora, C., Awandare, G.A., Kopydlowski, K.M., Czege, J., Moch, J.K., Finberg, R.W., Tsokos, G.C., Stoute, J.A., Complement receptor 1 is a sialic acid-independent erythrocyte receptor of Plasmodium falciparum. PLoS Pathog., 6, 2010, e1000968.
52. Spring, M.D., Cummings, J.F., Ockenhouse, C.F., Dutta, S., Reidler, R., Angov, E., Bergmann-Leitner, E., Stewart, V.A., Bittner, S., Juompan, L., et al. Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A. PLoS One, 4, 2009, e5254.
53. Stubbs, J., Simpson, K.M., Triglia, T., Plouffe, D., Tonkin, C.J., Duraisingh, M.T., Maier, A.G., Winzeler, E.A., Cowman, A.F., Molecular mechanism for switching of P. falciparum invasion pathways into human erythrocytes. Science 309 (2005), 1384–1387.
54. Tas, S.W., Klickstein, L.B., Barbashov, S.F., Nicholson-Weller, A., C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion. J. Immunol. 163 (1999), 5056–5063.
55. Taylor, P.R., Seixas, E., Walport, M.J., Langhorne, J., Botto, M., Complement contributes to protective immunity against reinfection by Plasmodium chabaudi chabaudi parasites. Infect. Immun. 69 (2001), 3853–3859.
56. Tham, W.H., Wilson, D.W., Lopaticki, S., Schmidt, C.Q., Tetteh-Quarcoo, P.B., Barlow, P.N., Richard, D., Corbin, J.E., Beeson, J.G., Cowman, A.F., Complement receptor 1 is the host erythrocyte receptor for Plasmodium falciparum PfRh4 invasion ligand. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 17327–17332.
57. Waki, S., Uehara, S., Kanbe, K., Nariuch, H., Suzuki, M., Interferon-gamma and the induction of protective IgG2a antibodies in non-lethal Plasmodium berghei infections of mice. Parasite Immunol. 17 (1995), 503–508.
58. Ward, P.A., Sterzel, R.B., Lucia, H.L., Campbell, G.H., Jack, R.M., Complement does not facilitate plasmodial infections. J. Immunol. 126 (1981), 1826–1828.
59. Wold Health Organization, World Malaria Report 2013. 2013 (Geneva).
60. Yoneto, T., Waki, S., Takai, T., Tagawa, Y., Iwakura, Y., Mizuguchi, J., Nariuchi, H., Yoshimoto, T., A critical role of Fc receptor-mediated antibody-dependent phagocytosis in the host resistance to blood-stage Plasmodium berghei XAT infection. J. Immunol. 166 (2001), 6236–6241.